TThis study is looking at developing a treatment medication for obesity management and Type-2 diabetes.
This new drug mimics the actions of a hormone called GLP-1 (glucagon-like peptide 1) that is naturally produced in the body. At this stage we want to see how the medication is absorbed by the human body, so we are looking for healthy participants with no medical conditions.
This clinical trial has been approved by an independent ethics committee, and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!